Health News Archive - April 21, 2009
Vast clinical specimen library and open health databank promise to speed scientific discovery. MILWAUKEE, April 21 /PRNewswire/ -- Aurora Health Care announces the launch of its Open-Source Robotic Biorepository & Informatics Technology, ORBIT.
Identifies potential clinical trial strategies for personalized approach to cancer treatment SEATTLE, April 21 /PRNewswire-FirstCall/ -- Systems Medicine, LLC (SM), a wholly-owned subsidiary of Cell Therapeutics, Inc.
Consumers may want to see healthier food items available but that does not mean they will choose them, U.S. researchers said. Study authors Keith Wilcox of City University of New York, Beth Vallen of Loyola College, Lauren Block of City University of New York and Gavan J.
VENLO, Netherlands and KOLKATA, India, April 21 /PRNewswire-Asia/ -- QIAGEN and the Chittaranjan National Cancer Institute (CNCI) today announced a collaboration to establish the first large-scale cervical cancer screening program for women in Kolkata, India.
Mayo Clinic Health Manager, Powered by Microsoft HealthVault, Helps You and Your Family Become Better Organized, Better Informed ROCHESTER, Minn. and REDMOND, Wash., April 21 /PRNewswire/ -- Mayo Clinic and Microsoft Corp.
CORONA DEL MAR, Calif., April 21 /PRNewswire/ -- Patient Safety Week was March 8-14. Promoting the use of the automated blood pressure device (1979), the pulse oximeter (1983) and the brain activity monitor (1997) was never for personal financial profit.
OXFORD, England, April 21 /PRNewswire/ -- Circassia Ltd, a specialty biopharmaceutical company focused on allergy, announced today that it has initiated a phase II clinical study of its ToleroMune(R) technology in allergy patients with asthma.
In Clinical Test, NutriSystem D Leads to Weight Loss, Lower Blood Sugar and Improved A1C HORSHAM, Pa., April 21 /PRNewswire-FirstCall/ -- NutriSystem (Nasdaq: NTRI), a leading weight loss program that delivers to your door, today announced the launch of new NutriSystem D, a weight loss program designed specifically for the approximately 24 million Americans with diabetes, as well as the 57 million Americans who are at risk for diabetes.
goBalto establishes new online platform to help pharmaceutical companies find, evaluate and manage drug partners from around the world, reducing inefficiencies in the drug development lifecycle SAN FRANCISCO, April 21 /PRNewswire/ -- goBalto, an online drug development partnering site for the pharmaceutical development and drug manufacturing industry, announced today its new platform and website, goBalto.com.
SOUTHAMPTON, England, April 21 /PRNewswire/ -- Vantia Therapeutics, a company developing novel small molecule drugs targeting large underserved medical markets, today announces the appointment of Rachel Morten as Head of Regulatory Affairs. Rachel has more than 24 years experience in global regulatory affairs and product development in the pharmaceutical and animal health industries.